Eargo
A company made up of ENT surgeons, tech geeks and dreamers, united in our belief that people should be able to hear life to the fullest.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Merger | |
| Total Funding | 000k | ||
Maveron(exited)
NEA(exited)
Charles Schwab(exited)
Dolby Family Ventures(exited)
Pierre Lamond(exited)
Farzad (Zod) Nazem(exited)
Red Sea Ventures(exited)
Crosslink Capital(exited)
Peterson Ventures(exited)
Montage Ventures(exited)
Birchmere Ventures(exited)
Future Fund(exited)
Schwab Institutional(exited)
Gilde Healthcare(exited)
Longitude Capital(exited)
Patient Square Capital(exited)
StartX(exited)
Nan Fung Life Sciences(exited)
Todd Kimmel(exited)
Sean Sebastian(exited)
Florent Michel(exited)
LXE Hearing(exited)
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 250 % | 42 % | 111 % | (54 %) | 16 % | 4 % | (5 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (141 %) | (129 %) | (53 %) | (475 %) | (419 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (146 %) | (136 %) | (58 %) | (491 %) | (423 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 41 % | 39 % | 17 % | 79 % | 51 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.